V. Rider et al., GENDER DIFFERENCES IN AUTOIMMUNE-DISEASES - ESTROGEN INCREASES CALCINEURIN EXPRESSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical immunology and immunopathology (Print), 89(2), 1998, pp. 171-180
Systemic lupus erythematosus (SLE) predominantly affects women (9:1 co
mpared to men) of childbearing age and often decreases its intensity i
n postmenopausal women, suggesting that sex hormones play a role in it
s pathogenesis. Comparison of steady-state levels of calcineurin mRNA
using RNase protection assays revealed increased calcineurin expressio
n in response to estradiol in cultured T cells from nine female lupus
patients. Calcineurin mRNA levels did not increase significantly in T
cells from eight age-matched normal control female volunteers. Estroge
n-dependent calcineurin mRNA increased in a dose-dependent fashion, wh
ile progesterone and dexamethasone did not increase calcineurin mRNA i
n patient cells. Lupus T cell calcineurin mRNA increased in response t
o estradiol at 6 h but not at 3 h. Calcineurin phosphatase activity in
creased in lupus T cell extracts after incubation of cells with estrad
iol, while phosphatase activity in normal T cells was unaffected by es
trogen. Calcineurin expression in T cells from patients with vasculiti
s and rheumatoid arthritis taking medications similar to those taken b
y the lupus patients was unaffected by estradiol. This study provides
the first evidence for a molecular marker of estrogen action in lupus
patients and suggests that estrogen-dependent changes in lupus T cell
calcineurin could alter proinflammatory cytokine gene regulation and T
-B cell interactions. (C) 1998 Academic Press.